Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Topical Application
100%
Sheep
100%
Beta-blockers
100%
Full-thickness Burns
100%
Re-epithelialization
100%
Epithelialization Period
100%
Blood Flow
75%
Treatment Group
75%
Full-thickness Wound
75%
Timolol
75%
Quantitative PCR
50%
Day 14
50%
Myofibroblast Activation
50%
MRNA Abundance
50%
Epithelial-mesenchymal Transition
50%
Wound Healing
25%
Ovine Model
25%
Survival Analysis
25%
Gene Products
25%
Blood Glucose
25%
Glaucoma
25%
No Significant Difference
25%
Tachycardia
25%
Wound Epithelialization
25%
Paired T-test
25%
Clinical Scenarios
25%
Related Pathway
25%
Hypertension Management
25%
Blood Perfusion
25%
Burn Wound Healing
25%
Cardiovascular Hemodynamics
25%
Blood RNA
25%
Posterior Surface
25%
Planimetric
25%
Potential Influencing Factors
25%
β-adrenergic Receptor Blocker
25%
Medicine and Dentistry
Beta Adrenergic Receptor Blocking Agent
100%
Thermal Burn
100%
Topical Drug Administration
100%
Epithelization
100%
Wound
57%
Blood Flow
42%
Timolol
42%
Treatment Group
42%
Wound Healing
28%
Mesenchymal-Epithelial Transition
28%
Myofibroblast
28%
Real-Time Polymerase Chain Reaction
14%
Survival Analysis
14%
Reverse Transcription Polymerase Chain Reaction
14%
Blood Glucose
14%
Hemodynamic
14%
Gene Product
14%
Glaucoma
14%
Eschar
14%
Tachyarrhythmia
14%
Student T Test
14%
Hypertension
14%
Nursing and Health Professions
Thermal Burn
100%
Beta Adrenergic Receptor Blocking Agent
100%
Topical Drug Administration
100%
Wound
80%
Blood Flow
60%
Treatment Group
60%
Timolol
60%
Wound Healing
40%
Survival Analysis
20%
Glucose Blood Level
20%
Tachycardia
20%
Glaucoma
20%
Perfusion
20%
Student T Test
20%
Polymerase Chain Reaction
20%
Hemodynamic
20%
Efficacy
20%
Hypertension
20%
Pharmacology, Toxicology and Pharmaceutical Science
Beta Adrenergic Receptor Blocking Agent
100%
Sheep
100%
Wound
80%
Burn
60%
Timolol
60%
Treatment Group
60%
Wound Healing
40%
Ovine Model
20%
Glaucoma
20%
Tachycardia
20%
Glucose
20%
Hypertension
20%